)
Company research29 Apr 2026
Target Corporation: The Business Behind the Bullseye
How Target grew from a Minneapolis dry goods store into a retail giant, blending discount pricing with design and private-label power.
Ovid Therapeutics
Ovid Therapeutics (OVID) investor relations material
Ovid Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary27 Apr, 2026
Executive summary
Annual meeting scheduled for June 10, 2026, with virtual participation available to shareholders.
Shareholders are encouraged to review proxy materials and vote by June 9, 2026.
Voting matters and shareholder proposals
Election of Jeremy M. Levin, DPhil, MB BChir, as Class III director is up for vote.
Advisory vote on executive compensation for named executive officers is included.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Board has nominated Jeremy M. Levin for election as Class III director.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Ovid Therapeutics
- Pipeline advances, strong safety, and financing extend cash runway into late 2028 or 2029.OVID
Q4 202529 Apr 2026 - Director election, say-on-pay, auditor ratification, and governance updates headline the 2026 proxy.OVIDProxy filing27 Apr 2026
- OV4071 advances as a first-in-class oral KCC2 activator for broad, safe psychosis treatment.OVIDStatus update26 Apr 2026
- Registering 29.9M shares for resale after $60M private placement; no resale proceeds to company.OVIDRegistration filing22 Apr 2026
- OV329 and OV4071 advance in clinical trials, targeting epilepsy and CNS disorders.OVIDLeerink Global Healthcare Conference 202611 Mar 2026
- OV329 and OV4071 advance in CNS disorders, with major clinical data expected within 18 months.OVIDTD Cowen 46th Annual Health Care Conference4 Mar 2026
- OV329 showed strong safety and potent inhibition, supporting Phase 2a trials in epilepsy.OVIDStudy Result23 Jan 2026
- $62.7M cash, $14M Q3 loss, $29M royalty gain, cash runway into H2 2026.OVIDQ3 202423 Jan 2026
- Q2 2024 net income reached $8.5M after a 43% workforce cut and $29M royalty liability gain.OVIDQ2 202423 Jan 2026
Next Ovid Therapeutics earnings date
Q1 202613 May, 2026
Ovid Therapeutics
Next Ovid Therapeutics earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Frequently asked questions
Explore our global coverage